ID   TTK_HUMAN               Reviewed;         857 AA.
AC   P33981; A8K8U5; B2RDW2; E1P543; Q15272; Q5TCS0; Q9BW51; Q9NTM0;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   10-MAY-2017, entry version 181.
DE   RecName: Full=Dual specificity protein kinase TTK;
DE            EC=2.7.12.1;
DE   AltName: Full=Phosphotyrosine picked threonine-protein kinase;
DE            Short=PYT;
GN   Name=TTK; Synonyms=MPS1, MPS1L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1639825;
RA   Mills G.B., Schmandt R., McGill M., Amendola A., Hill M., Jacobs K.,
RA   May C., Rodricks A.-M., Campbell S., Hogg D.;
RT   "Expression of TTK, a novel human protein kinase, is associated with
RT   cell proliferation.";
RL   J. Biol. Chem. 267:16000-16006(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 504-802 (ISOFORM 1/2), AND
RP   CHARACTERIZATION.
RX   PubMed=7678926;
RA   Lindberg R.A., Fischer W.H., Hunter T.;
RT   "Characterization of a human protein threonine kinase isolated by
RT   screening an expression library with antibodies to phosphotyrosine.";
RL   Oncogene 8:351-359(1993).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 525-792 (ISOFORM 1/2).
RX   PubMed=1956325; DOI=10.1016/0076-6879(91)00126-H;
RA   Hanks S.K., Quinn A.M.;
RT   "Protein kinase catalytic domain sequence database: identification of
RT   conserved features of primary structure and classification of family
RT   members.";
RL   Methods Enzymol. 200:38-62(1991).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-821, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [10]
RP   FUNCTION, AND MUTAGENESIS OF ASP-664.
RX   PubMed=18243099; DOI=10.1016/j.cell.2007.11.046;
RA   Jelluma N., Brenkman A.B., van den Broek N.J., Cruijsen C.W.A.,
RA   van Osch M.H.J., Lens S.M.A., Medema R.H., Kops G.J.P.L.;
RT   "Mps1 phosphorylates Borealin to control Aurora B activity and
RT   chromosome alignment.";
RL   Cell 132:233-246(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; THR-33; SER-37;
RP   SER-80; SER-281; SER-317; SER-393; SER-436 AND SER-821, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33; SER-321; SER-393 AND
RP   SER-821, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   INTERACTION WITH TPR.
RX   PubMed=19273613; DOI=10.1083/jcb.200811012;
RA   Lince-Faria M., Maffini S., Orr B., Ding Y., Florindo C., Sunkel C.E.,
RA   Tavares A., Johansen J., Johansen K.M., Maiato H.;
RT   "Spatiotemporal control of mitosis by the conserved spindle matrix
RT   protein Megator.";
RL   J. Cell Biol. 184:647-657(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-7; THR-33; SER-281; SER-321; SER-436 AND
RP   SER-821, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33; SER-37; SER-281 AND
RP   SER-821, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; THR-33; SER-321;
RP   SER-436; SER-455 AND SER-821, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.88 ANGSTROMS) OF 510-857 OF APOPROTEIN AND IN
RP   COMPLEX WITH SP600125, AND MUTAGENESIS OF ASP-664 AND THR-686.
RX   PubMed=18480048; DOI=10.1074/jbc.M803026200;
RA   Chu M.L.H., Chavas L.M.G., Douglas K.T., Eyers P.A., Tabernero L.;
RT   "Crystal structure of the catalytic domain of the mitotic checkpoint
RT   kinase Mps1 in complex with SP600125.";
RL   J. Biol. Chem. 283:21495-21500(2008).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 515-857.
RX   PubMed=19120698; DOI=10.1111/j.1582-4934.2008.00605.x;
RA   Wang W., Yang Y., Gao Y., Xu Q., Wang F., Zhu S., Old W., Resing K.,
RA   Ahn N., Lei M., Liu X.;
RT   "Structural and mechanistic insights into Mps1 kinase activation.";
RL   J. Cell. Mol. Med. 13:1679-1694(2009).
CC   -!- FUNCTION: Phosphorylates proteins on serine, threonine, and
CC       tyrosine. Probably associated with cell proliferation. Essential
CC       for chromosome alignment by enhancing AURKB activity (via direct
CC       CDCA8 phosphorylation) at the centromere, and for the mitotic
CC       checkpoint. {ECO:0000269|PubMed:18243099}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Inhibited by the ATP-competitive kinase
CC       inhibitor, SP600125.
CC   -!- SUBUNIT: Interacts with TPR; the interactions occurs in a
CC       microtubule-independent manner. {ECO:0000269|PubMed:18480048,
CC       ECO:0000269|PubMed:19273613}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P33981-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P33981-2; Sequence=VSP_043072;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Present in rapidly proliferating cell lines.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA61239.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAB87580.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M86699; AAA61239.1; ALT_INIT; mRNA.
DR   EMBL; AK292460; BAF85149.1; -; mRNA.
DR   EMBL; AK315696; BAG38059.1; -; mRNA.
DR   EMBL; AL133475; CAB87580.1; ALT_INIT; Genomic_DNA.
DR   EMBL; CH471051; EAW48699.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48700.1; -; Genomic_DNA.
DR   EMBL; BC000633; AAH00633.1; -; mRNA.
DR   EMBL; BC032858; AAH32858.1; -; mRNA.
DR   EMBL; X70500; CAA49912.1; -; mRNA.
DR   CCDS; CCDS4993.1; -. [P33981-1]
DR   CCDS; CCDS55040.1; -. [P33981-2]
DR   PIR; A42861; A42861.
DR   RefSeq; NP_001160163.1; NM_001166691.1. [P33981-2]
DR   RefSeq; NP_003309.2; NM_003318.4. [P33981-1]
DR   RefSeq; XP_011534401.1; XM_011536099.2. [P33981-1]
DR   RefSeq; XP_011534402.1; XM_011536100.2. [P33981-2]
DR   UniGene; Hs.169840; -.
DR   PDB; 2X9E; X-ray; 3.10 A; A=514-828.
DR   PDB; 2ZMC; X-ray; 3.14 A; A=510-857.
DR   PDB; 2ZMD; X-ray; 2.88 A; A=510-857.
DR   PDB; 3CEK; X-ray; 2.30 A; A=519-808.
DR   PDB; 3DBQ; X-ray; 2.70 A; A=515-857.
DR   PDB; 3GFW; X-ray; 2.74 A; A=519-808.
DR   PDB; 3H9F; X-ray; 2.60 A; A=519-808.
DR   PDB; 3HMN; X-ray; 2.70 A; A=510-809.
DR   PDB; 3HMO; X-ray; 2.40 A; A=510-809.
DR   PDB; 3HMP; X-ray; 2.30 A; A=510-809.
DR   PDB; 3VQU; X-ray; 2.40 A; A=516-820.
DR   PDB; 3W1F; X-ray; 2.70 A; A=516-820.
DR   PDB; 3WYX; X-ray; 2.90 A; A=516-820.
DR   PDB; 3WYY; X-ray; 3.05 A; A=516-820.
DR   PDB; 3WZJ; X-ray; 2.75 A; A=516-820.
DR   PDB; 3WZK; X-ray; 2.30 A; A=516-820.
DR   PDB; 4B94; X-ray; 2.20 A; A/B/C/D=62-239.
DR   PDB; 4BHZ; X-ray; 2.85 A; A=519-808.
DR   PDB; 4BI0; X-ray; 2.84 A; A=519-808.
DR   PDB; 4BI1; X-ray; 2.70 A; A=519-808.
DR   PDB; 4BI2; X-ray; 3.11 A; A=519-808.
DR   PDB; 4C4E; X-ray; 2.60 A; A=519-808.
DR   PDB; 4C4F; X-ray; 2.36 A; A=519-808.
DR   PDB; 4C4G; X-ray; 2.65 A; A=519-808.
DR   PDB; 4C4H; X-ray; 2.80 A; A=519-808.
DR   PDB; 4C4I; X-ray; 2.65 A; A=519-808.
DR   PDB; 4C4J; X-ray; 2.50 A; A=519-808.
DR   PDB; 4CV8; X-ray; 3.00 A; A=519-808.
DR   PDB; 4CV9; X-ray; 2.50 A; A=519-808.
DR   PDB; 4CVA; X-ray; 2.50 A; A=519-808.
DR   PDB; 4D2S; X-ray; 2.50 A; A=514-795.
DR   PDB; 4H7X; X-ray; 2.60 A; A/B=55-210.
DR   PDB; 4H7Y; X-ray; 1.80 A; A/B/C/D=55-210.
DR   PDB; 4JS8; X-ray; 1.94 A; A=515-795.
DR   PDB; 4JT3; X-ray; 2.20 A; A=515-795.
DR   PDB; 4O6L; X-ray; 2.38 A; A/B=515-795.
DR   PDB; 4ZEG; X-ray; 2.33 A; A=515-795.
DR   PDB; 5AP0; X-ray; 2.15 A; A=519-808.
DR   PDB; 5AP1; X-ray; 2.05 A; A=519-808.
DR   PDB; 5AP2; X-ray; 2.80 A; A=519-808.
DR   PDB; 5AP3; X-ray; 2.70 A; A=519-808.
DR   PDB; 5AP4; X-ray; 2.85 A; A=519-808.
DR   PDB; 5AP5; X-ray; 2.80 A; A=519-808.
DR   PDB; 5AP6; X-ray; 2.10 A; A=519-808.
DR   PDB; 5AP7; X-ray; 2.45 A; A=519-808.
DR   PDB; 5EH0; X-ray; 2.18 A; A=519-794.
DR   PDB; 5EHL; X-ray; 2.66 A; A=519-808.
DR   PDB; 5EHO; X-ray; 2.18 A; A=519-808.
DR   PDB; 5EHY; X-ray; 2.26 A; A=519-808.
DR   PDB; 5EI2; X-ray; 2.67 A; A=519-808.
DR   PDB; 5EI6; X-ray; 2.01 A; A=519-808.
DR   PDB; 5EI8; X-ray; 2.17 A; A=519-753.
DR   PDB; 5LJJ; X-ray; 3.00 A; A=519-808.
DR   PDBsum; 2X9E; -.
DR   PDBsum; 2ZMC; -.
DR   PDBsum; 2ZMD; -.
DR   PDBsum; 3CEK; -.
DR   PDBsum; 3DBQ; -.
DR   PDBsum; 3GFW; -.
DR   PDBsum; 3H9F; -.
DR   PDBsum; 3HMN; -.
DR   PDBsum; 3HMO; -.
DR   PDBsum; 3HMP; -.
DR   PDBsum; 3VQU; -.
DR   PDBsum; 3W1F; -.
DR   PDBsum; 3WYX; -.
DR   PDBsum; 3WYY; -.
DR   PDBsum; 3WZJ; -.
DR   PDBsum; 3WZK; -.
DR   PDBsum; 4B94; -.
DR   PDBsum; 4BHZ; -.
DR   PDBsum; 4BI0; -.
DR   PDBsum; 4BI1; -.
DR   PDBsum; 4BI2; -.
DR   PDBsum; 4C4E; -.
DR   PDBsum; 4C4F; -.
DR   PDBsum; 4C4G; -.
DR   PDBsum; 4C4H; -.
DR   PDBsum; 4C4I; -.
DR   PDBsum; 4C4J; -.
DR   PDBsum; 4CV8; -.
DR   PDBsum; 4CV9; -.
DR   PDBsum; 4CVA; -.
DR   PDBsum; 4D2S; -.
DR   PDBsum; 4H7X; -.
DR   PDBsum; 4H7Y; -.
DR   PDBsum; 4JS8; -.
DR   PDBsum; 4JT3; -.
DR   PDBsum; 4O6L; -.
DR   PDBsum; 4ZEG; -.
DR   PDBsum; 5AP0; -.
DR   PDBsum; 5AP1; -.
DR   PDBsum; 5AP2; -.
DR   PDBsum; 5AP3; -.
DR   PDBsum; 5AP4; -.
DR   PDBsum; 5AP5; -.
DR   PDBsum; 5AP6; -.
DR   PDBsum; 5AP7; -.
DR   PDBsum; 5EH0; -.
DR   PDBsum; 5EHL; -.
DR   PDBsum; 5EHO; -.
DR   PDBsum; 5EHY; -.
DR   PDBsum; 5EI2; -.
DR   PDBsum; 5EI6; -.
DR   PDBsum; 5EI8; -.
DR   PDBsum; 5LJJ; -.
DR   ProteinModelPortal; P33981; -.
DR   SMR; P33981; -.
DR   BioGrid; 113123; 72.
DR   DIP; DIP-40642N; -.
DR   IntAct; P33981; 35.
DR   MINT; MINT-1203816; -.
DR   STRING; 9606.ENSP00000358813; -.
DR   BindingDB; P33981; -.
DR   ChEMBL; CHEMBL3983; -.
DR   GuidetoPHARMACOLOGY; 2264; -.
DR   iPTMnet; P33981; -.
DR   PhosphoSitePlus; P33981; -.
DR   BioMuta; TTK; -.
DR   DMDM; 160112977; -.
DR   EPD; P33981; -.
DR   MaxQB; P33981; -.
DR   PaxDb; P33981; -.
DR   PeptideAtlas; P33981; -.
DR   PRIDE; P33981; -.
DR   DNASU; 7272; -.
DR   Ensembl; ENST00000230510; ENSP00000230510; ENSG00000112742. [P33981-2]
DR   Ensembl; ENST00000369798; ENSP00000358813; ENSG00000112742. [P33981-1]
DR   Ensembl; ENST00000509894; ENSP00000422936; ENSG00000112742. [P33981-2]
DR   GeneID; 7272; -.
DR   KEGG; hsa:7272; -.
DR   UCSC; uc003pjb.5; human. [P33981-1]
DR   CTD; 7272; -.
DR   DisGeNET; 7272; -.
DR   GeneCards; TTK; -.
DR   HGNC; HGNC:12401; TTK.
DR   HPA; CAB010166; -.
DR   HPA; CAB013229; -.
DR   MIM; 604092; gene.
DR   neXtProt; NX_P33981; -.
DR   OpenTargets; ENSG00000112742; -.
DR   PharmGKB; PA37066; -.
DR   eggNOG; KOG0596; Eukaryota.
DR   eggNOG; ENOG410XRRQ; LUCA.
DR   GeneTree; ENSGT00790000123008; -.
DR   HOGENOM; HOG000013174; -.
DR   HOVERGEN; HBG001029; -.
DR   InParanoid; P33981; -.
DR   KO; K08866; -.
DR   OMA; MSCFRTP; -.
DR   OrthoDB; EOG091G0GP7; -.
DR   PhylomeDB; P33981; -.
DR   TreeFam; TF105420; -.
DR   BRENDA; 2.7.12.1; 2681.
DR   SignaLink; P33981; -.
DR   SIGNOR; P33981; -.
DR   EvolutionaryTrace; P33981; -.
DR   GeneWiki; TTK_(gene); -.
DR   GenomeRNAi; 7272; -.
DR   PRO; PR:P33981; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112742; -.
DR   CleanEx; HS_TTK; -.
DR   ExpressionAtlas; P33981; baseline and differential.
DR   Genevisible; P33981; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0000776; C:kinetochore; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc.
DR   GO; GO:0051304; P:chromosome separation; IEA:InterPro.
DR   GO; GO:0016321; P:female meiosis chromosome segregation; IEA:Ensembl.
DR   GO; GO:0033316; P:meiotic spindle assembly checkpoint; IEA:Ensembl.
DR   GO; GO:0007094; P:mitotic spindle assembly checkpoint; TAS:ProtInc.
DR   GO; GO:0007052; P:mitotic spindle organization; TAS:ProtInc.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; TAS:BHF-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0034501; P:protein localization to kinetochore; IEA:Ensembl.
DR   GO; GO:1903096; P:protein localization to meiotic spindle midzone; IEA:Ensembl.
DR   GO; GO:0007051; P:spindle organization; TAS:ProtInc.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR027084; Prot_kin_Mps1_fam.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR011990; TPR-like_helical_dom.
DR   PANTHER; PTHR22974:SF25; PTHR22974:SF25; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    857       Dual specificity protein kinase TTK.
FT                                /FTId=PRO_0000086774.
FT   DOMAIN      525    791       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     531    539       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    647    647       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     553    553       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES       7      7       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      33     33       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES      80     80       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     281    281       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     317    317       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     321    321       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     393    393       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976}.
FT   MOD_RES     436    436       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     455    455       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     821    821       Phosphoserine.
FT                                {ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     420    420       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043072.
FT   VARIANT      97     97       A -> V (in dbSNP:rs2230513).
FT                                /FTId=VAR_037141.
FT   VARIANT     758    758       D -> N (in dbSNP:rs2230512).
FT                                /FTId=VAR_037142.
FT   MUTAGEN     664    664       D->A: Loss of kinase activity.
FT                                {ECO:0000269|PubMed:18243099,
FT                                ECO:0000269|PubMed:18480048}.
FT   MUTAGEN     686    686       T->A: Loss of kinase activity.
FT                                {ECO:0000269|PubMed:18480048}.
FT   CONFLICT    389    389       S -> A (in Ref. 1; AAA61239).
FT                                {ECO:0000305}.
FT   CONFLICT    768    768       L -> V (in Ref. 7; CAA49912 and 8).
FT                                {ECO:0000305}.
FT   HELIX        62     75       {ECO:0000244|PDB:4H7Y}.
FT   HELIX        81     97       {ECO:0000244|PDB:4H7Y}.
FT   HELIX       100    103       {ECO:0000244|PDB:4H7Y}.
FT   HELIX       107    123       {ECO:0000244|PDB:4H7Y}.
FT   HELIX       125    127       {ECO:0000244|PDB:4H7Y}.
FT   HELIX       129    138       {ECO:0000244|PDB:4H7Y}.
FT   HELIX       143    155       {ECO:0000244|PDB:4H7Y}.
FT   HELIX       159    171       {ECO:0000244|PDB:4H7Y}.
FT   HELIX       177    188       {ECO:0000244|PDB:4H7Y}.
FT   STRAND      517    520       {ECO:0000244|PDB:4JS8}.
FT   STRAND      523    533       {ECO:0000244|PDB:4JS8}.
FT   STRAND      535    543       {ECO:0000244|PDB:4JS8}.
FT   STRAND      549    556       {ECO:0000244|PDB:4JS8}.
FT   HELIX       557    559       {ECO:0000244|PDB:5EHO}.
FT   HELIX       562    577       {ECO:0000244|PDB:4JS8}.
FT   TURN        578    581       {ECO:0000244|PDB:4JS8}.
FT   STRAND      583    585       {ECO:0000244|PDB:5EH0}.
FT   STRAND      588    593       {ECO:0000244|PDB:4JS8}.
FT   STRAND      595    602       {ECO:0000244|PDB:4JS8}.
FT   STRAND      606    608       {ECO:0000244|PDB:4JS8}.
FT   HELIX       609    614       {ECO:0000244|PDB:4JS8}.
FT   STRAND      616    618       {ECO:0000244|PDB:3W1F}.
FT   HELIX       621    640       {ECO:0000244|PDB:4JS8}.
FT   HELIX       650    652       {ECO:0000244|PDB:4JS8}.
FT   STRAND      653    656       {ECO:0000244|PDB:4JS8}.
FT   STRAND      659    662       {ECO:0000244|PDB:4JS8}.
FT   STRAND      666    668       {ECO:0000244|PDB:4JS8}.
FT   TURN        686    689       {ECO:0000244|PDB:4JT3}.
FT   HELIX       692    696       {ECO:0000244|PDB:4JS8}.
FT   HELIX       713    729       {ECO:0000244|PDB:4JS8}.
FT   TURN        733    736       {ECO:0000244|PDB:4JS8}.
FT   HELIX       740    748       {ECO:0000244|PDB:4JS8}.
FT   STRAND      750    752       {ECO:0000244|PDB:4JS8}.
FT   HELIX       762    771       {ECO:0000244|PDB:4JS8}.
FT   TURN        776    778       {ECO:0000244|PDB:4JS8}.
FT   HELIX       782    785       {ECO:0000244|PDB:4JS8}.
FT   HELIX       789    792       {ECO:0000244|PDB:4JS8}.
SQ   SEQUENCE   857 AA;  97072 MW;  51F40A3CD1677AC5 CRC64;
     MESEDLSGRE LTIDSIMNKV RDIKNKFKNE DLTDELSLNK ISADTTDNSG TVNQIMMMAN
     NPEDWLSLLL KLEKNSVPLS DALLNKLIGR YSQAIEALPP DKYGQNESFA RIQVRFAELK
     AIQEPDDARD YFQMARANCK KFAFVHISFA QFELSQGNVK KSKQLLQKAV ERGAVPLEML
     EIALRNLNLQ KKQLLSEEEK KNLSASTVLT AQESFSGSLG HLQNRNNSCD SRGQTTKARF
     LYGENMPPQD AEIGYRNSLR QTNKTKQSCP FGRVPVNLLN SPDCDVKTDD SVVPCFMKRQ
     TSRSECRDLV VPGSKPSGND SCELRNLKSV QNSHFKEPLV SDEKSSELII TDSITLKNKT
     ESSLLAKLEE TKEYQEPEVP ESNQKQWQSK RKSECINQNP AASSNHWQIP ELARKVNTEQ
     KHTTFEQPVF SVSKQSPPIS TSKWFDPKSI CKTPSSNTLD DYMSCFRTPV VKNDFPPACQ
     LSTPYGQPAC FQQQQHQILA TPLQNLQVLA SSSANECISV KGRIYSILKQ IGSGGSSKVF
     QVLNEKKQIY AIKYVNLEEA DNQTLDSYRN EIAYLNKLQQ HSDKIIRLYD YEITDQYIYM
     VMECGNIDLN SWLKKKKSID PWERKSYWKN MLEAVHTIHQ HGIVHSDLKP ANFLIVDGML
     KLIDFGIANQ MQPDTTSVVK DSQVGTVNYM PPEAIKDMSS SRENGKSKSK ISPKSDVWSL
     GCILYYMTYG KTPFQQIINQ ISKLHAIIDP NHEIEFPDIP EKDLQDVLKC CLKRDPKQRI
     SIPELLAHPY VQIQTHPVNQ MAKGTTEEMK YVLGQLVGLN SPNSILKAAK TLYEHYSGGE
     SHNSSSSKTF EKKRGKK
//
